loader image
Saturday, December 20, 2025
84.8 F
McAllen
- Advertisement -

Encouraging Cancer Screenings During Cervical Health Awareness Month 

Translate to Spanish or other 102 languages!

 As part of National Cervical Health Awareness Month this January, the Texas Health and Human Services Commission is encouraging women to get screened for cervical cancer. Image for illustration purposes
 As part of National Cervical Health Awareness Month this January, the Texas Health and Human Services Commission is encouraging women to get screened for cervical cancer. Image for illustration purposes
- Advertisement -

AUSTIN, Texas – As part of National Cervical Health Awareness Month this January, the Texas Health and Human Services Commission is encouraging women to get screened for cervical cancer.

“Routine cervical cancer screening is the most effective way to detect cervical cancer early,” said Faith Sandberg-Rodriguez, associate commissioner of Family Clinical Services at HHSC. “However, many potentially eligible Texas women may not know about services in their area or experience other barriers to accessing care. HHSC helps low-income women access timely cervical cancer screening and diagnostic services.”

Cervical cancer is the third-leading cancer diagnosis for women ages 20-39 and fifth-leading for women ages 40-49. According to the Texas Cancer Registry, an estimated 1,489 Texas women were diagnosed with cervical cancer. The Centers for Disease Control and Prevention (CDC) recommend cervical cancer screenings for women ages 21–65.

- Advertisement -

The HHSC Breast and Cervical Cancer Services (BCCS) program provides low-cost and free women’s health services for uninsured and underinsured Texas women who meet eligibility requirements. Services include cervical and breast cancer screenings, clinical breast examinations, mammograms and breast biopsies.

BCCS helps fund clinics across the state that provide these lifesaving screening and diagnostic services. In fiscal year 2022, BCCS served 30,422 women, including 5,717 women who received cervical cancer screenings.

The BCCS program is partly funded through the CDC. The National Breast and Cervical Cancer Early Detection Program awards funding to states for early detection of cervical and breast cancers. For fiscal year 2024, the federal program awarded BCCS more than $8.3 million. The Texas Legislature appropriated an additional $3.4 million in state funding.

To find BCCS providers or learn more about women’s health services, visit the Healthy Texas Women website or call 2-1-1. For more information on how breast and cervical cancer services are provided to Texas women, view “Breast and Cervical Cancer Services: 2023 Statewide Look.”

- Advertisement -

About National Cervical Health Awareness Month

National Cervical Health Awareness Month is observed in January in the U.S. Efforts throughout the month raise awareness about cervical cancer and provide education about prevention, screening and treatments. More information about cervical cancer is posted on the CDC website.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×